Rapid Micro Biosystems (RPID) Amortization of Deferred Charges (2020 - 2026)

Rapid Micro Biosystems (RPID) posted Amortization of Deferred Charges of $86000.0 for Q1 2026, up 17.81% sequentially from $73000.0 in Q4 2025.

Rapid Micro Biosystems (RPID) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Rapid Micro Biosystems has reported Amortization of Deferred Charges for 4 years, with the latest figure at $86000.0 in Q1 2026.

Quarterly Amortization of Deferred Charges changed N/A year-over-year to $86000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $159000.0 (changed N/A YoY) and the FY2025 annual result came in at $97000.0, changed N/A from the prior year.
Amortization of Deferred Charges grew to $86000.0 in Q1 2026 per RPID's latest filing, from $73000.0 in the prior quarter.
Over five years, Amortization of Deferred Charges peaked at $86000.0 in Q1 2026 and troughed at $73000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Rapid Micro Biosystems	80.26 Mn	60.49 Mn	1.21 Mn

Download Data